GENTIAN DIAGNOSTICS ASA (GENT.OL) Fundamental Analysis & Valuation
OSL:GENT • NO0010748866
Current stock price
44.3 NOK
+1.8 (+4.24%)
Last:
This GENT.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GENT.OL Profitability Analysis
1.1 Basic Checks
- In the past year GENT was profitable.
- GENT had a positive operating cash flow in the past year.
- In multiple years GENT reported negative net income over the last 5 years.
- In multiple years GENT reported negative operating cash flow during the last 5 years.
1.2 Ratios
- GENT has a better Return On Assets (5.13%) than 69.84% of its industry peers.
- The Return On Equity of GENT (6.47%) is comparable to the rest of the industry.
- The Return On Invested Capital of GENT (8.73%) is better than 74.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.13% | ||
| ROE | 6.47% | ||
| ROIC | 8.73% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 7.51%, GENT is in the better half of the industry, outperforming 60.32% of the companies in the same industry.
- GENT has a better Operating Margin (14.42%) than 71.43% of its industry peers.
- The Gross Margin of GENT (55.64%) is comparable to the rest of the industry.
- GENT's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.42% | ||
| PM (TTM) | 7.51% | ||
| GM | 55.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.99%
GM growth 5Y2.77%
2. GENT.OL Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so GENT is still creating some value.
- There is no outstanding debt for GENT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 8.42 indicates that GENT is not in any danger for bankruptcy at the moment.
- The Altman-Z score of GENT (8.42) is better than 93.65% of its industry peers.
- GENT has a debt to FCF ratio of 0.61. This is a very positive value and a sign of high solvency as it would only need 0.61 years to pay back of all of its debts.
- With an excellent Debt to FCF ratio value of 0.61, GENT belongs to the best of the industry, outperforming 93.65% of the companies in the same industry.
- A Debt/Equity ratio of 0.09 indicates that GENT is not too dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.09, GENT belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.61 | ||
| Altman-Z | 8.42 |
ROIC/WACC1.02
WACC8.53%
2.3 Liquidity
- GENT has a Current Ratio of 5.40. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
- GENT has a Current ratio of 5.40. This is amongst the best in the industry. GENT outperforms 96.83% of its industry peers.
- GENT has a Quick Ratio of 3.81. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
- GENT has a better Quick ratio (3.81) than 95.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.4 | ||
| Quick Ratio | 3.81 |
3. GENT.OL Growth Analysis
3.1 Past
- The earnings per share for GENT have decreased strongly by -70.75% in the last year.
- GENT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.07%.
- GENT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.75% yearly.
EPS 1Y (TTM)-70.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.41%
Revenue 1Y (TTM)16.07%
Revenue growth 3Y20.2%
Revenue growth 5Y22.75%
Sales Q2Q%9.35%
3.2 Future
- Based on estimates for the next years, GENT will show a very strong growth in Earnings Per Share. The EPS will grow by 79.21% on average per year.
- Based on estimates for the next years, GENT will show a quite strong growth in Revenue. The Revenue will grow by 19.00% on average per year.
EPS Next Y204.65%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
EPS Next 5YN/A
Revenue Next Year19.34%
Revenue Next 2Y20.77%
Revenue Next 3Y19%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. GENT.OL Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 52.12, which means the current valuation is very expensive for GENT.
- 61.90% of the companies in the same industry are cheaper than GENT, based on the Price/Earnings ratio.
- Compared to an average S&P500 Price/Earnings ratio of 27.87, GENT is valued quite expensively.
- Based on the Price/Forward Earnings ratio of 16.58, the valuation of GENT can be described as correct.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of GENT indicates a somewhat cheap valuation: GENT is cheaper than 68.25% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 38.51. GENT is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 52.12 | ||
| Fwd PE | 16.58 |
4.2 Price Multiples
- GENT's Enterprise Value to EBITDA is on the same level as the industry average.
- Based on the Price/Free Cash Flow ratio, GENT is valued a bit cheaper than the industry average as 74.60% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.46 | ||
| EV/EBITDA | 16.46 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as GENT's earnings are expected to grow with 79.21% in the coming years.
PEG (NY)0.25
PEG (5Y)N/A
EPS Next 2Y113.5%
EPS Next 3Y79.21%
5. GENT.OL Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 1.46%, GENT has a reasonable but not impressive dividend return.
- In the last 3 months the price of GENT has falen by -27.05%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
- Compared to an average industry Dividend Yield of 1.23, GENT pays a bit more dividend than its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.82, GENT has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.46% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 46.54% of the earnings are spent on dividend by GENT. This is a bit on the high side, but may be sustainable.
DP46.54%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
GENT.OL Fundamentals: All Metrics, Ratios and Statistics
OSL:GENT (4/17/2026, 7:00:00 PM)
44.3
+1.8 (+4.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners39.64%
Inst Owner ChangeN/A
Ins Owners2.68%
Ins Owner ChangeN/A
Market Cap683.11M
Revenue(TTM)176.50M
Net Income(TTM)13.26M
Analysts85.71
Price Target64.26 (45.06%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.46% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP46.54%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-17.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 52.12 | ||
| Fwd PE | 16.58 | ||
| P/S | 3.87 | ||
| P/FCF | 21.46 | ||
| P/OCF | 16.04 | ||
| P/B | 3.33 | ||
| P/tB | 4.04 | ||
| EV/EBITDA | 16.46 |
EPS(TTM)0.85
EY1.92%
EPS(NY)2.67
Fwd EY6.03%
FCF(TTM)2.06
FCFY4.66%
OCF(TTM)2.76
OCFY6.23%
SpS11.45
BVpS13.29
TBVpS10.97
PEG (NY)0.25
PEG (5Y)N/A
Graham Number15.9437 (-64.01%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.13% | ||
| ROE | 6.47% | ||
| ROCE | 11.34% | ||
| ROIC | 8.73% | ||
| ROICexc | 16.54% | ||
| ROICexgc | 23.72% | ||
| OM | 14.42% | ||
| PM (TTM) | 7.51% | ||
| GM | 55.64% | ||
| FCFM | 18.03% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.99%
GM growth 5Y2.77%
F-Score6
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.61 | ||
| Debt/EBITDA | 0.56 | ||
| Cap/Depr | 118.04% | ||
| Cap/Sales | 6.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 123.21% | ||
| Profit Quality | 240.13% | ||
| Current Ratio | 5.4 | ||
| Quick Ratio | 3.81 | ||
| Altman-Z | 8.42 |
F-Score6
WACC8.53%
ROIC/WACC1.02
Cap/Depr(3y)95.7%
Cap/Depr(5y)120.92%
Cap/Sales(3y)5.54%
Cap/Sales(5y)9.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.41%
EPS Next Y204.65%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
EPS Next 5YN/A
Revenue 1Y (TTM)16.07%
Revenue growth 3Y20.2%
Revenue growth 5Y22.75%
Sales Q2Q%9.35%
Revenue Next Year19.34%
Revenue Next 2Y20.77%
Revenue Next 3Y19%
Revenue Next 5YN/A
EBIT growth 1Y61.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year128%
EBIT Next 3Y57.14%
EBIT Next 5YN/A
FCF growth 1Y1169.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y216.49%
OCF growth 3YN/A
OCF growth 5YN/A
GENTIAN DIAGNOSTICS ASA / GENT.OL Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for GENTIAN DIAGNOSTICS ASA?
ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL.
Can you provide the valuation status for GENTIAN DIAGNOSTICS ASA?
ChartMill assigns a valuation rating of 5 / 10 to GENTIAN DIAGNOSTICS ASA (GENT.OL). This can be considered as Fairly Valued.
What is the profitability of GENT stock?
GENTIAN DIAGNOSTICS ASA (GENT.OL) has a profitability rating of 4 / 10.
What are the PE and PB ratios of GENTIAN DIAGNOSTICS ASA (GENT.OL) stock?
The Price/Earnings (PE) ratio for GENTIAN DIAGNOSTICS ASA (GENT.OL) is 52.12 and the Price/Book (PB) ratio is 3.33.
What is the earnings growth outlook for GENTIAN DIAGNOSTICS ASA?
The Earnings per Share (EPS) of GENTIAN DIAGNOSTICS ASA (GENT.OL) is expected to grow by 204.65% in the next year.